Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Guizhou Sanli Pharmaceutical Co., Ltd., founded in 1995, is a modern traditional Chinese patent medicines and simple preparations pharmaceutical enterprise integrating R&D, production and sales. The company's product line mainly focuses on the fields of pediatrics, respiratory system department, cardio cerebrovascular department, gastroenterology department, etc. The main products are Kaihoujian spray (children's type), Kaihoujian spray, Qiangli Gastrodia elata Duzhong capsule, etc. Among them, the core products Kaihoujian Spray (children's type) and Kaihoujian Spray are national patented products, which occupy a high market share in the traditional Chinese patent medicines and simple preparations spray market for throat diseases, and have formed a certain brand awareness in the field of throat diseases and traditional Chinese patent medicines and simple preparations for children. According to the statistics of Southern Research Institute, Kaihoujian Spray (including children's type) has ranked No.1 in the market of traditional Chinese patent medicines and simple preparations spray for throat diseases for three consecutive years, and No.1 in the hospital terminal market of traditional Chinese patent medicines and simple preparations spray for throat diseases for six consecutive years. Since its establishment, Guizhou Sanli has always adhered to the quality policy of quality first, adhering to reputation, and providing dedicated services. With the new version of GMP as the minimum control standard, it strives for excellence and continuous improvement. After long-term development and accumulation, the company has won multiple honors such as National High tech Enterprise and Top 100 Private Enterprises in Guizhou. Multiple products have been rated as Guizhou Famous Brand Products and trademarks have been rated as Guizhou Famous Trademarks. It has been included in the Guizhou Intellectual Property Advantage Cultivation Enterprise Database. In the future, Guizhou Sanli will, as always, adhere to the development of traditional Chinese patent medicines and simple preparations as the core, inherit the excellent historical and cultural traditions of traditional Chinese medicine, continue to promote traditional Chinese medicine, ethnic medicine, Miao medicine and other classic famous prescriptions. Aiming at the current multiple diseases, relying on the technical concept of the modernization of traditional Chinese medicine, with the goal of constantly improving product quality and user experience, Guizhou Sanli is committed to being the leader in the subdivided fields. Adhering to the corporate mission of "creating a healthy life for mankind", and moving towards the vision of "becoming a trusted pharmaceutical enterprise for the Chinese people", we will take practical actions to fulfill our commitment to stable development in the entire pharmaceutical and health industry.
Headquarter Anshun
Establish Date 9/22/1995
Listed Code 603439.SH
Listed Date 4/28/2020
Chairman Zhang Hai.
CEO Zhang Hai.
Website www.gz-sanli.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial